Tube Feeding Error: Fatal Medical Mistakes
... -- The American Society for parenteral and Enteral Nutrition (A.S.P.E.N.), whose mission ... and more. The American Society for parenteral and Enteral Nutrition (A.S.P.E.N.) is dedicated ... of clinical nutrition therapies, including parenteral and enteral nutrition. With more than 5,500 ...B. Braun Medical Wins Two GHX 2009 Best in Class Awards
... Recognized for Continued Market Leadership in parenteral and Solutions/Nutritionals BETHLEHEM, Pa., ... share growth for distributed products in the parenteral and Solutions/Nutritionals product categories for ... and CEO of B. Braun Medical Inc. "Our success in parenteral and Solutions/Nutritionals, like all of our ...Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety
... HealthCare Nutrition and the American Society for parenteral and Enteral Nutrition, or A.S.P.E.N., today ... About A.S.P.E.N. The American Society for parenteral and Enteral Nutrition is dedicated to improving ... of clinical nutrition therapies, including parenteral and enteral nutrition. With more than 5,500 ...Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome
... compound that may reduce dependence upon parenteral nutrition (PN) in patients with intestinal ... the potential to reduce or eliminate the need for parenteral nutrition, thereby reducing the complications ... Short Bowel Syndrome (SBS) Patients Dependent On parenteral Nutrition: a Multicenter, Multinational ...Short-term hemofiltration is cost-effective for severe acute pancreatitis
... route group. Conventional routes included total parenteral nutrition and nasojejunal enteral nutrition. ... is regarded as an indispensable approach. Total parenteral nutrition and gastrointestinal tract rest have ... outcomes compared with the conventional total parenteral or jejunal enteral routes. Gastrointestinal ...Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
... use in the U.S since 1992. Important Safety Information The parenteral use of complexes of iron and carbohydrates has resulted in ... the acute phase of infectious kidney disease. Unwarranted therapy with parenteral iron will cause excess storage of iron with the consequent possibility of ...Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America
... and other unexplored fields in Robotics pharmacy automation such as total parenteral nutrition," stated Werner Rainer, Health Robotics' CEO. About ... and marketing of plasma derivates, IV therapy solutions, enteral and parenteral nutrition, diagnostic systems, pharmacy automation, and medical materials ...Story of Woman's Courage and Medical Innovation Top Choice for Readers
... feeding and nutrition helped form the medical foundation of Total parenteral Nutrition, or TPN, as it is known today. With thousands of patients in ... United Kingdom, The Netherlands and Germany went on Home TPN or Home parenteral Nutrition at 39 per cent followed by people suffering from Crohn's (19 per ...Baxter Reports Strong Third Quarter Sales and Earnings
... a result of strong global sales of anesthesia, intravenous solutions and parenteral nutrition products. Renal revenues of $0.6 billion increased 8 percent, as ... in home dialysis therapy. -- A joint venture to produce and sell parenteral nutrition products in China as Guangzhou Baxter Qiaoguang Healthcare ...NPS Reports Successful GATTEX(TM) Extension Study
... for short bowel syndrome (SBS) patients who are dependent upon parenteral nutrition (PN). The extension study enrolled 65 of the 71 patients (91%) ... effective potential therapy for short bowel syndrome patients dependent on parenteral Nutrition. This study provides interesting and very promising results, as ...BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
... peramivir as a treatment option for an influenza emergency," said Jon P. Stonehouse, President and Chief Executive Officer of BioCryst. "With its parenteral route of administration, peramivir has the potential to help patients who may have difficulty with an oral or inhaled anti-viral medication. In ...Schering-Plough Announces Results of the Early ACS Trial
... within the preceding six weeks; history of stroke within 30 days, or any history of hemorrhagic stroke; current or planned administration of another parenteral GP IIb-IIIa inhibitor; dependency on renal dialysis; or known hypersensitivity to any component of the product. In patients undergoing PCI, ...DaVita Abstracts Highlight Latest Research Developments at Annual Dialysis Conference
... Technique with Keloid-Scarred Skin Sylvia Donato-Moore, BSN, RN, CNN -- Experience with Intradialytic parenteral Nutrition at a Pediatric Hemodialysis Unit Kathleen Traficanti, BS, RD -- NxStage(R) Pureflow SL Culture and LAL ...Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
... as sodium sulfide, in a number of disease models. Preclinical data demonstrate the therapeutic potential of IK-1001 (sodium sulfide) for injection, a parenteral injectable formulation of hydrogen sulfide, in a variety of disease models including myocardial infarction, cardiopulmonary bypass surgery, ...Genta Receives Key Patent Related to Oral Gallium Compound G4544
... Company to Seek Buyer for Marketed parenteral Product Ganite(R) BERKELEY HEIGHTS, N.J., April 14 /PRNewswire/ -- Genta Incorporated (Nasdaq: GNTA ) today announced that the Company has ...Novel therapy combinations gain ground in treating hepatitis
... forms of hepatitis exist, including hepatitis A, B and C. Hepatitis A is generally food-borne, while hepatitis B and C are spread primarily through parenteral or sexual routes. The disease is often caused by a virus, but can also result from alcohol, toxins or drugs. "Despite the significant number of ...ImClone Systems and Lonza Walkersville to Discuss Paperless QC Micro at PDA Annual Meeting
... Las Vegas, NV (PRWEB) April 16, 2009 -- The parenteral Drug Association (PDA) is hosting their annual ... reagents to licensed test kits to regulated parenteral products. For more information, visit www.lonza.com . About PDA The parenteral Drug Association (PDA) is the leading global ...Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
... occurs between cycles of intermittent parenteral therapy. Effects of continuous Azacitidine ... the first time." Pharmion currently markets the parenteral formulation of azacitidine, known as Vidaza(R) ... orally administered Azacitidine, as compared with parenteral Vidaza. An oral dosage formulation of ...Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
... Director of Contract Manufacturing at Ben Venue Laboratories where he was responsible for Sales, Marketing and New Business Development for its parenteral contract manufacturing services business. Prior to Ben Venue, Dan was the Vice President of Business Operations at Boehringer Ingelheim Chemicals ...Regado Biosciences Expands Medical Advisory Board
... effect providing a safe and unique approach to personalized medicine. Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents, the first being a potent and highly selective Factor IXa inhibitor (RB006) and the second being its complementary active control agent ...B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices
... for its smart pump technology based on KLAS's 2008 Top 20 Best in KLAS Report for Smart Pump Technology. B. Braun's PINNACLE(R) TPN (total parenteral nutrition) Management System represented a significant advancement in automated compounding technology, incorporating the most rigorous safety ...Regado Biosciences Establishes Medical Advisory Board
... each system's therapeutic effect providing a safe and unique approach to personalized medicine. Regado's lead program, REG1, is comprised of two parenteral agents, the first being a potent and highly selective Factor IXa inhibitor (RB006) and the second being its complementary active control agent ...Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
... (API), the capsule formulation, greater efficacy and reduced side effects. Sales of Sinobiopharma's formulation of L-alanyl-L-glutamine for parenteral (intravenous) nutrition are projected to exceed 30,000 units in 2009. The Company is in the process of submitting its application for ...Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008
... areas, and to comfortably plan to develop a third robot [TPNstation] as part of a new strategic partnership expanding from IV Therapy into the parenteral Nutrition market in FY2010. We expect the demonstrate TPNstation at ASHP 2009 Mid Year Meeting in Las Vegas." stated Werner Rainer, CEO of Health ...